NEW YORK (GenomeWeb News) – More than 98 percent of Life Technologies' voting shareholders have approved the company's pending $13.6 billion acquisition by Thermo Fisher Scientific, Life Tech announced after the close of the market on Wednesday.

The voting took place at a special shareholders' meeting on Wednesday, and the 98 percent of votes cast in favor of the deal represents more than 72 percent of all outstanding shares, Life Tech said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.